Cell Isolation & Preparation
Plan neutrophil enrichment, red blood cell removal, recovery, and viability assessment before downstream experiments.
Build a connected view of neutrophil biology—from cell preparation and phenotypic characterization to functional readouts, NET-associated markers, and disease-context validation.
Explore a modular framework organized around experimental questions. Select the starting point that best matches your sample, model, and intended readout.
Plan neutrophil enrichment, red blood cell removal, recovery, and viability assessment before downstream experiments.
Characterize neutrophil populations and activation or maturation states using species-appropriate marker combinations.
Investigate chemotaxis, phagocytosis, oxidative burst, degranulation, and granule-associated enzyme activity.
Study NET-associated processes using complementary molecular markers, cellular morphology, extracellular DNA, and appropriate controls.
Choose readouts according to whether the question concerns individual markers, extracellular nucleic acids, or marker complexes such as MPO–DNA.
Interrogate PAD-associated pathways, ROS-linked mechanisms, and MPO/NE activity while considering selectivity and off-target effects.
Connect neutrophil identity and NET-associated signals with histopathology, tissue localization, and multiplex marker combinations.
Combine cell identity, functional readouts, molecular markers, and tissue context to build a more defensible interpretation.
Shortlist research tools by species, sample type, application, detection platform, and validation requirements.
NETosis is biologically heterogeneous and stimulus-dependent. A robust study should combine complementary evidence rather than rely on a single marker.
Extracellular DNA, citrullinated histones, MPO, and neutrophil elastase can each provide useful evidence, but none alone is universally sufficient to establish NET formation. Readouts should be matched to the biological question and experimental model.
RECOMMENDED STUDY LOGIC
A modular workflow for NETosis-related investigations.
01 Prepare & characterize
Establish sample quality, cell identity, viability, and baseline state.
02 Stimulate & observe
Optimize stimulus, dose, timing, and imaging or sampling strategy.
03 Cross-validate
Combine molecular markers with orthogonal functional or morphological evidence.
04 Interpret in context
Evaluate tissue localization and disease-related signals with relevant controls.
Start with the intended readout—marker detection, enzyme activity, extracellular DNA, or tissue imaging—and confirm product availability and application fit.
Before interpreting a signal, evaluate sample suitability, assay performance, marker specificity, and the biological context.
Purity, recovery, viability, processing time, isolation-induced activation, and donor-to-donor variability.
Positive and negative controls, dynamic range, cell viability, stimulus timing, and potential assay interference.
Distinguish NET-associated signals from non-specific cell death and confirm whether the method detects a specific complex.
Tissue background, antibody specificity, co-localization, panel compatibility, and pathology controls.
Use morphology or imaging, molecular markers, and functional evidence that fit the study question.
Find relevant experimental modules by research question, from innate immune function to tissue injury and spatially resolved validation.
APPLICATION 01
Investigate NET-associated processes, molecular markers, and potential induction or inhibition mechanisms.
APPLICATION 02
Explore links between NETs, platelets, coagulation, endothelial injury, and vascular inflammation.
APPLICATION 03
Study tumor-associated neutrophil states, immune modulation, metastasis, and treatment response.
APPLICATION 04
Evaluate host defense, inflammatory amplification, ROS, MPO/NE-associated signals, and tissue damage.
APPLICATION 05
Use markers such as CD10, CD16, CD62L, or Ly6G—where appropriate—to examine maturation and activation states.
APPLICATION 06
Combine flow phenotyping, tissue IF/IHC, multiplex staining, and spatial evidence to investigate tissue-specific populations.
A curated selection of influential reviews and perspectives covering core neutrophil biology, NETosis regulation, autoimmune inflammation, and neutrophil heterogeneity in cancer. These papers provide scientific context for planning fit-for-purpose experimental workflows.
Burn GL, Foti A, Marsman G, Patel DF, Zychlinsky A. Immunity. 2021;54(7):1377–1391.
A broad foundation for neutrophil antimicrobial activity, effector mechanisms, and contributions to infection, cancer, and inflammatory disease.
Hedrick CC, Malanchi I. Nature Reviews Immunology. 2022;22:173–187. Published online in 2021.
Explains context-dependent neutrophil diversity in tumors and systemic compartments, supporting phenotype-aware profiling rather than a one-marker interpretation.
Wigerblad G, Kaplan MJ. Nature Reviews Immunology. 2023;23:274–288.
Reviews how NETs may contribute to inflammatory amplification and organ damage, informing studies that pair NET-associated markers with disease context.
Palomino-Segura M, Sicilia J, Ballesteros I, et al. Nature Immunology. 2023;24:575–584.
Discusses how tissue specialization, transcriptional variability, and inflammatory environments can shape neutrophil states and functions.
Zanoni I, et al. Trends in Microbiology. 2023;31(3):280–293.
Highlights cell-intrinsic and external regulators of NET release, including histone modification, GSDMD, metabolism, and intercellular crosstalk.
Eruslanov E, Nefedova Y, Gabrilovich DI. Nature Immunology. 2025;26:17–28.
A recent synthesis of tumor-associated neutrophil diversity and therapeutic implications, relevant to tumor microenvironment and immune-modulation research.
This framework maps research questions to product categories and common readouts. Antibodies, assays, and recombinant proteins are presented together by experimental need; specific SKUs and performance claims must be confirmed against the current Ucallm catalog.
Explore the tools by experimental need. Recombinant proteins are integrated into the same map as antibodies and assays—supporting stimulation, pathway interrogation, enzyme studies, and NET clearance. All protein examples below are research-planning candidates; confirm availability, species, bioactivity, and catalog details against the approved Ucallm catalog before publication.
NETOSIS / NET MARKERS
Research tools for detecting selected NET-associated markers, such as citrullinated histones, MPO, and neutrophil elastase, subject to product-specific validation.
IDENTITY & PHENOTYPING
Candidate marker categories include human CD66b, CD15, CD16, CD10 and CD62L, and mouse Ly6G, alongside broader myeloid markers where appropriate.
FUNCTIONAL BIOLOGY
Potential assay categories include oxidative burst, chemotaxis, phagocytosis, degranulation, and enzyme activity measurements.
NET FORMATION & QUANTIFICATION
Potential approaches include extracellular DNA measurements, fluorescence imaging, morphology-based assessment, and complementary functional readouts.
NET-ASSOCIATED COMPLEXES
For studies requiring a complex-specific readout, confirm that the method detects the intended analyte rather than an individual component alone.
TISSUE & MULTIPLEX VALIDATION
Combine neutrophil identity markers with selected NET-associated targets to investigate localization in infection, thrombosis, cancer, and tissue injury models.
RECOMBINANT PROTEINS · CHEMOTAXIS
Support studies of chemotaxis, recruitment, inflammatory priming, and activation. Select the protein by species, receptor biology, cell source, and the specific functional question.
RECOMBINANT PROTEINS · NETOSIS
Investigate stimulus-dependent NET formation and platelet–neutrophil or damage-associated molecular pattern signaling. Use the protein as a defined experimental input alongside appropriate NET-associated readouts.
RECOMBINANT ENZYMES · NET CLEARANCE
Explore extracellular DNA degradation, NET clearance, and enzyme-dependent mechanisms. Recombinant enzymes may also support defined substrate or biochemical studies.
RECOMBINANT PROTEINS · DISEASE CONTEXT
Connect neutrophil biology to granulopoiesis, tumor-associated states, vascular inflammation, and immunothrombosis. Pair protein perturbation with phenotype and tissue-level validation.
Use this planning matrix to align study objectives, product categories, and validation criteria.
| Research Module | Product / Tool Category | Typical Targets or Readouts | Key Selection & Validation Points |
|---|---|---|---|
| Cell isolation & preparation | Isolation/enrichment, red blood cell removal, viability assessment | Density gradients, negative selection, magnetic separation | Species fit, purity, recovery, viability, processing time |
| Identity & phenotype | Flow cytometry, IF/IHC, immunoblotting antibodies | Human: CD11b, CD66b, CD16, CD15, CD10, CD62L; mouse: Ly6G, CD11b | Species and clone, fluorophore compatibility, gating, tissue background |
| Core function | Chemotaxis, phagocytosis, ROS/oxidative burst, degranulation, enzyme activity | ROS, MPO, NE/ELANE, selected cytokines | Controls, dynamic range, viability, assay interference |
| Protein stimulation & pathway studies | Recombinant cytokines, chemokines, ligands, and enzymes | CXCL8/IL-8, CXCL1/CXCL2, C5a, TNF-α, GM-CSF; selected enzyme tools | Species fit, endotoxin, formulation, biological activity, dose/time optimization |
| NETosis formation | Functional readouts, extracellular DNA staining, imaging | NE activity, extracellular DNA, morphology and nuclear changes | Stimulus, time window, readout specificity, cell-death confounding |
| NET-associated molecules | Complex-specific measurements and single-marker quantification | MPO–DNA, CitH3, MPO, NE, cfDNA | Sample matrix, complex specificity, quantitation, nuclease effects |
| Mechanism & screening | Enzyme activity, inhibitors, pathway tools | PAD4/PAD2-associated pathways, ROS-linked mechanisms, MPO/NE | Substrate specificity, selectivity, off-target effects, orthogonal validation |
| Disease & tissue validation | ELISA, IF/IHC, multiplex IF, spatial validation | Neutrophil identity markers plus NET-associated markers | Tissue context, co-localization, panel compatibility, pathology controls |
Scientific framework adapted from the supplied “Neutrophil Research” source document. Product availability, catalog numbers, technical claims, and links require Ucallm internal verification before release.
Share your species, sample type, research question, and detection platform to develop a focused product shortlist and a fit-for-purpose validation workflow.
(function(){const buttons=[...document.querySelectorAll('.filter-btn')];const cards=[...document.querySelectorAll('.product-card')];buttons.forEach(btn=>btn.addEventListener('click',()=>{buttons.forEach(b=>b.classList.toggle('active',b===btn));const f=btn.dataset.filter;cards.forEach(card=>{card.style.display=(f==='all'||card.dataset.category.split(' ').includes(f))?'flex':'none';});}));})();
Reach our technical and product support team through your preferred channel.
info@mail.ucallm.com
+(1)-866-986-9598
Online Quote Submission
+(1)-866-986-9598